Analysis of Plasma Epstein–Barr Virus <scp>DNA</scp> and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in <scp>KEYNOTE</scp> ‐122

Anthony T. C. Chan, Victor Ho Fun Lee, Ruey‐Long Hong, Myung‐Ju Ahn, Wan Qin Chong, Anna Spreafico, Sung‐Bae Kim, Gwo Fuang Ho, Priscilla B. Caguioa, Nuttapong Ngamphaiboon, Ramona F. Swaby, Bo Wei, Andrea L. Webber, John Kang, Burak Gumuscu, Jianda Yuan, Lillian L. Siu

Open source

DOI: 10.1002/cam4.71496
Published: 2026-02
Container: Cancer Medicine
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/cam4.71496,
  title = {Analysis of Plasma Epstein–Barr Virus
                    <scp>DNA</scp>
                    and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in
                    <scp>KEYNOTE</scp>
                    ‐122},
  author = {Anthony T. C. Chan and Victor Ho Fun Lee and Ruey‐Long Hong and Myung‐Ju Ahn and Wan Qin Chong and Anna Spreafico and Sung‐Bae Kim and Gwo Fuang Ho and Priscilla B. Caguioa and Nuttapong Ngamphaiboon and Ramona F. Swaby and Bo Wei and Andrea L. Webber and John Kang and Burak Gumuscu and Jianda Yuan and Lillian L. Siu},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.71496},
  url = {https://doi.org/10.1002/cam4.71496}
}

RIS

TY  - JOUR
TI  - Analysis of Plasma Epstein–Barr Virus
                    <scp>DNA</scp>
                    and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in
                    <scp>KEYNOTE</scp>
                    ‐122
AU  - Anthony T. C. Chan
AU  - Victor Ho Fun Lee
AU  - Ruey‐Long Hong
AU  - Myung‐Ju Ahn
AU  - Wan Qin Chong
AU  - Anna Spreafico
AU  - Sung‐Bae Kim
AU  - Gwo Fuang Ho
AU  - Priscilla B. Caguioa
AU  - Nuttapong Ngamphaiboon
AU  - Ramona F. Swaby
AU  - Bo Wei
AU  - Andrea L. Webber
AU  - John Kang
AU  - Burak Gumuscu
AU  - Jianda Yuan
AU  - Lillian L. Siu
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.71496
UR  - https://doi.org/10.1002/cam4.71496
ER  -

APA

Chan, A. T. C., Lee, V. H. F., Hong, R., Ahn, M., Chong, W. Q., Spreafico, A., Kim, S., Ho, G. F., Caguioa, P. B., Ngamphaiboon, N., Swaby, R. F., Wei, B., Webber, A. L., Kang, J., Gumuscu, B., Yuan, J., & Siu, L. L. (2026). Analysis of Plasma Epstein–Barr Virus <scp>DNA</scp> and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in <scp>KEYNOTE</scp> ‐122. Cancer Medicine. https://doi.org/10.1002/cam4.71496

Source records

crossref · retrieved 2026-09-27T02:38:21.609Z